Author response for "Nirsevimab effectiveness against RSV-related hospitalisations in children under 24 months: a test-negative case–control study in Portugal, 2024–2025"Vânia Gaio, VigiRSV group, Miguel Lança et al.|Unknown|2025Cited by 0